Cinnasil From Panray With Rescinnamine 0.5mg

Ingredients: Rescinnamine
Dosage Form and Administration: Capsule; Oral
Drug Trade Name: Cinnasil
Firm: Panray
Strength: 0.5MG
New Drug Application Type: A
Drug Application Number:84736
Product Number: 1
Approval Date: 1/1/1982
Reference Listed Drug: No
Type: DISCN
Applicant Full Name: Panray Corp Sub Ormont Drug And Chemical Co Inc

Paying for Drug and Alcohol Treatment

Finding ways to pay for treatment to recover from dependence on alcohol or drugs takes some research. Addiction treatment can be quite costly and the wrong program can be ineffective. The severity and duration of the substance a person abuses and the type of treatment the person requires all contribute to the costs.
Some treatment for drug and alcohol dependence costs more than others. Residential treatment is more expensive than outpatient treatment. The location of the facility, amenities offered and staffing also influence treatment costs. Chronic alcoholism or drug abuse may require longer-term treatment and that can become very costly depending on the treatment facility.

Determine the Payment Approach

The goal of every drug and alcohol abuse treatment center is to help the patient to abstain from use, to be able to function again normally and re-enter society and to stay in recovery--clean and sober. In an ideal world, no treatment facility would turn any client away for lack of ability to pay. In reality, not every drug and alcohol treatment center can do this because of fixed costs. Still, there are various methods available for assisting clients pay for treatment.

Private Insurance

The most commonly used payment for drug and alcohol treatment is through private insurance. The insurance coverage may pay for some or a great portion of the drug and alcohol treatment program. The websites of some addiction treatment centers may mention specific insurance carriers, particularly if the facilities are preferred addiction treatment centers for national insurance companies such as Blue Cross, Aetna, Cigna and others. Whether or not private insurance covers any portion of drug and alcohol treatment depends on whether the facilities are ERISA or non-ERISA plans. The Employee Retirement and Income Security Act (ERISA) is a federal law that sets standards for certain health plans offered by employers. If the plan is ERISA, it may or may not cover drug and alcohol treatment, as it is not required to. Non-ERISA plans and other group health plans, are required to provide at least four inpatient detox admissions (of up to 7 days each) in a lifetime, at least 30 days per year (lifetime 90 days) of non-hospital residential treatment and at least 30 days a year of partial hospitalization or outpatient services.

Military Insurance

Members of the armed services who need alcohol or substance abuse treatment may have some or most of the costs paid for through military insurance.

Medicare, Medicaid and Medical

Many treatment facilities advertise that accepting Medicare, Medicaid and Medical. Medicare Part A covers some drug and alcohol treatment received at a hospital (including room, meals, nursing and some other services), while Part B covers some services provided by alcohol and drug professionals (inpatient or outpatient), lab tests, partial hospitalization and outpatient therapies. Be aware that Medicare does not cover the total cost of most treatment and services and patients pay deductibles and co-payments.

Self Payment

The two major things to consider when evaluating self payment for addiction treatment are that the first attempts at drug and alcohol treatments do not always work. Ongoing addiction usually has high mental and financial costs as well as increased risk for other problems.

Drug Abuse Crime Connection

It is easy to see the connection between drug abuse and crime. Drug abuse is criminal in the following ways: drug possession or sales; to drug abuse e.g., stealing to get money for drugs; and a drug abuse lifestyle that predisposes the drug abuser to engage in illegal activity, like associating with other offenders or dealing in illicit markets. Individuals who use illicit drugs are more likely to commit crimes and it is common for individuals who had used drugs or alcohol to commit many offenses, including violent crimes.
After a nationally representative survey of state correctional agencies in 2005, Criminal Justice Drug Abuse Treatment Studies (CJ–DATS) investigators estimated that nearly 8 million adults were involved in the justice system (Taxman, Young, Wiersema, et al., 2007). Almost 5 million individuals are on probation or under parole supervision (Glaze and Bonczar, 2006; Taxman, Young, Wiersema, et al., 2007), with drug law violators accounting for the largest percentage of these parolees. The substance abuse or dependence rates of offenders are more than four times that of the general population (National Institute of Justice, 2003; U.S. Department of Health and Human Services, 2006). In a 2004 survey, the Bureau of Justice Statistics BJS estimated that about 53 percent of state and 45 percent of federal prisoners met Diagnostic and Statistical Manual for Mental Disorders (DSM) criteria for drug abuse or dependence (Mumola and Karberg, 2006). Of those surveyed, 14.8 percent of state and 17.4 percent of federal prisoners reported having drug treatment since admission (Mumola and Karberg, 2006). Juvenile justice systems also report high levels of drug abuse. A survey of juvenile detainees in 2000 found that about 56 percent of the boys and 40 percent of the girls tested positive for drug use at the time of arrest (National Institute of Justice, 2003).
Although there has been an increased interest in providing substance abuse treatment services for criminal justice offenders, in the last decade, only a small percentage of offenders have access to adequate services, especially in jails and community correctional facilities (Taxman, Perdoni and Harrison, 2007). Not only is there a gap in the availability of these services for offenders, but often there are few choices in the types of services provided. Treatment is of insufficient quality and intensity or is not well suited to the needs of offenders and may not yield meaningful reductions in drug use and recidivism. Untreated substance abusing offenders are more likely to relapse to drug abuse and return to criminal behavior than treated offenders. Relapse can bring about re-arrest and re-incarceration, jeopardizing public health and public safety and taxing criminal justice system resources. Treatment offers the best alternative for interrupting the drug abuse/criminal justice cycle for offenders with drug abuse problems.
Drug abuse treatment can be incorporated into criminal justice settings in a variety of ways. These include treatment as a condition of probation; drug courts that blend judicial monitoring and sanctions with treatment; treatment in prison followed by community-based treatment after release; and treatment under parole or probation supervision. Actual drug abuse treatment efficiency can benefit from the cross-agency coordination and collaboration of criminal justice professionals, substance abuse treatment providers and other social service agencies. By working together, the criminal justice and treatment systems can optimize resources to benefit the health, safety and wellbeing of the individuals and communities they serve.